B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells.

B-cell receptor Chronic lymphocytic leukemia T helper cell antigen presentation human leukocyte antigen class II major histocompatibility complex class II phagocytosis

Journal

Exploration of targeted anti-tumor therapy
ISSN: 2692-3114
Titre abrégé: Explor Target Antitumor Ther
Pays: United States
ID NLM: 101770662

Informations de publication

Date de publication:
25 Feb 2022
Historique:
entrez: 21 3 2022
pubmed: 22 3 2022
medline: 22 3 2022
Statut: ppublish

Résumé

T-helper cells could play an important role in the pathogenesis of chronic lymphocytic leukemia (CLL), a common B-cell neoplasm. Although CLL cells can present soluble antigens targeted from the B-cell receptor to T-helper cells via major histocompatibility complex (MHC) class II, antigens recognized by some CLL cells may be encountered in a particulate form. Here the ability of CLL cells to internalize and present anti-immunoglobulin M (IgM) beads as a model for the interaction of CLL cells with particulate antigens was investigated. The effect of anti-IgM beads on antigen presentation pathways was analyzed using RNA-seq and internalization of anti-IgM beads by primary CLL cells was investigated using confocal microscopy and flow cytometry. Antigen presentation was investigated by analyzing activation of a T-cell line expressing a T-cell receptor specific for a peptide derived from mouse κ light chains after incubating CLL cells with a mouse κ light chain-containing anti-IgM monoclonal antibody. Kinase inhibitors were used to characterize the pathways mediating internalization and antigen presentation. Stimulation of surface IgM of CLL cells increased expression of the antigen presentation machinery and CLL cells were able to phagocytose anti-IgM beads. Internalization of anti-IgM beads was associated with MHC class II-restricted activation of cognate T-helper cells. Antigen presentation by CLL cells was dependent on activity of spleen tyrosine kinase (SYK) and phosphatidylinositol 3-kinase delta (PI3Kδ) but was unaffected by inhibitors of Bruton's tyrosine kinase (BTK). CLL cells can internalize and present antigen from anti-IgM beads. This capacity of CLL cells may be particularly important for recruitment of T-cell help

Identifiants

pubmed: 35309250
doi: 10.37349/etat.2022.00070
pmc: PMC7612515
mid: EMS143779
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37-49

Subventions

Organisme : Cancer Research UK
ID : A15581
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A18087
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A23669
Pays : United Kingdom

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare that they have no conflicts of interest.

Références

Int Immunol. 2002 Dec;14(12):1423-30
pubmed: 12456590
Mol Biol Cell. 2015 Apr 1;26(7):1273-85
pubmed: 25631815
Br J Haematol. 2004 Nov;127(4):404-15
pubmed: 15521917
Immunol Rev. 2020 Jul;296(1):48-61
pubmed: 32412663
Eur J Immunol. 2012 Apr;42(4):982-92
pubmed: 22531922
Clin Immunol. 2016 Nov;172:44-51
pubmed: 27586592
Blood. 2014 Feb 20;123(8):1229-38
pubmed: 24307721
Blood. 2010 May 13;115(19):3907-15
pubmed: 20110421
EMBO Rep. 2018 Sep;19(9):
pubmed: 29987136
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Blood. 2008 May 15;111(10):5173-81
pubmed: 18326821
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Exp Med. 2013 Jan 14;210(1):59-70
pubmed: 23296468
Br J Haematol. 1993 Nov;85(3):439-45
pubmed: 8136263
J Biol Chem. 1997 Feb 7;272(6):3641-7
pubmed: 9013617
Cell Rep. 2013 Aug 15;4(3):566-77
pubmed: 23933259
J Pharmacol Exp Ther. 2020 Mar;372(3):331-338
pubmed: 31871305
J Immunol. 2011 Sep 15;187(6):3064-71
pubmed: 21849672
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Arthritis Res Ther. 2011 Jul 13;13(4):R115
pubmed: 21752263
Blood. 2016 Jun 16;127(24):3015-25
pubmed: 27002119
Blood. 2007 May 15;109(10):4424-31
pubmed: 17255355
Blood. 2008 Apr 1;111(7):3838-48
pubmed: 18223168
Blood. 2011 May 19;117(20):5463-72
pubmed: 21385850
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80
pubmed: 20615965
Eur J Immunol. 2002 May;32(5):1403-13
pubmed: 11981828
Nat Rev Dis Primers. 2017 Jan 19;3:16096
pubmed: 28102226
J Immunol. 2009 Jan 1;182(1):329-39
pubmed: 19109164
Front Immunol. 2018 Mar 21;9:598
pubmed: 29619034
Sci Immunol. 2021 Aug 20;6(62):
pubmed: 34417258
Semin Cancer Biol. 2010 Dec;20(6):431-8
pubmed: 20920582
Traffic. 2016 May;17(5):487-99
pubmed: 26847957
Semin Cancer Biol. 2010 Dec;20(6):400-9
pubmed: 20863893
Immunity. 2016 Sep 20;45(3):471-482
pubmed: 27653600
Front Immunol. 2021 Jan 20;11:612244
pubmed: 33552073
J Immunol. 1999 Mar 1;162(5):2495-502
pubmed: 10072488
Br J Haematol. 2014 Jul;166(2):177-88
pubmed: 24697238
EMBO J. 2000 Feb 15;19(4):513-20
pubmed: 10675320
J Leukoc Biol. 2012 Apr;91(4):525-36
pubmed: 22058420
Leukemia. 2020 Aug;34(8):2012-2024
pubmed: 32457353
J Immunol. 2009 Jun 15;182(12):7473-81
pubmed: 19494270
J Immunol. 1996 Apr 15;156(8):2809-18
pubmed: 8609400
Mol Immunol. 2018 Sep;101:319-328
pubmed: 30036798
Mol Biol Cell. 2005 May;16(5):2339-48
pubmed: 15716350
Blood. 2013 Oct 10;122(15):2664-72
pubmed: 23954894
Immunity. 2011 Sep 23;35(3):361-74
pubmed: 21820334
Blood. 2012 Mar 8;119(10):2293-301
pubmed: 22234695
Biochem Biophys Res Commun. 1983 Dec 28;117(3):843-50
pubmed: 6607732
Front Immunol. 2019 Mar 13;10:415
pubmed: 30930895

Auteurs

Annabel R Minton (AR)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Lindsay D Smith (LD)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.
Current address: Ploughshare Innovations Limited, Porton Science Park, Porton Down, SP4 0BF Wiltshire, UK.

Dean J Bryant (DJ)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Jonathan C Strefford (JC)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Francesco Forconi (F)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Freda K Stevenson (FK)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

David A Tumbarello (DA)

Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, SO17 1BJ Southampton, UK.

Edd James (E)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Geir Åge Løset (GÅ)

Nextera AS, Gaustadalléen 21, NO-0349 Oslo, Norway.

Ludvig A Munthe (LA)

KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.

Andrew J Steele (AJ)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.
Current address: Janssen R&D, 1400 McKean Road, Spring House, Ambler, PA 19477, USA.

Graham Packham (G)

Cancer Research UK Centre, Cancer Sciences, Faculty of Medicine, University of Southampton, SO16 6YD Southampton, UK.

Classifications MeSH